Alliancebernstein L.P. Vericel Corp Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Vericel Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 57,890 shares of VCEL stock, worth $3.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

57,890

Previous 57,915 0.04%

Holding current value

$3.27 Million

Previous $2.66 Million 7.98%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$42.25 - $53.56 $1,056 - $1,339	-25 Reduced 0.04%	57,890 $2.45 Million
Q1 2024 May 14, 2024	BUY	$32.52 - $52.33 $121,787 - $195,975	3,745 Added 6.91%	57,915 $3.01 Million
Q4 2023 Feb 14, 2024	BUY	$30.85 - $37.09 $8,329 - $10,014	270 Added 0.5%	54,170 $1.93 Million
Q3 2023 Nov 14, 2023	SELL	$31.69 - $39.25 $1.79 Million - $2.21 Million	-56,370 Reduced 51.12%	53,900 $1.81 Million
Q2 2023 Aug 15, 2023	SELL	$29.0 - $38.37 $60,320 - $79,809	-2,080 Reduced 1.85%	110,270 $4.14 Million
Q1 2023 May 15, 2023	SELL	$23.85 - $31.34 $166,210 - $218,408	-6,969 Reduced 5.84%	112,350 $3.29 Million
Q4 2022 Feb 14, 2023	BUY	$17.65 - $27.37 $847 - $1,313	48 Added 0.04%	119,319 $3.14 Million
Q3 2022 Nov 15, 2022	BUY	$22.62 - $32.54 $418,243 - $601,664	18,490 Added 18.35%	119,271 $2.77 Million
Q2 2022 Aug 15, 2022	BUY	$22.88 - $39.45 $25,373 - $43,750	1,109 Added 1.11%	100,781 $2.54 Million
Q1 2022 May 13, 2022	BUY	$31.69 - $43.29 $5,260 - $7,186	166 Added 0.17%	99,672 $3.81 Million
Q4 2021 Feb 14, 2022	BUY	$35.2 - $52.6 $4,435 - $6,627	126 Added 0.13%	99,506 $3.91 Million
Q3 2021 Nov 10, 2021	SELL	$46.35 - $59.75 $139,050 - $179,250	-3,000 Reduced 2.93%	99,380 $4.85 Million
Q2 2021 Jul 30, 2021	BUY	$47.2 - $67.81 $2.06 Million - $2.96 Million	43,630 Added 74.26%	102,380 $5.38 Million
Q1 2021 May 06, 2021	BUY	$30.93 - $59.48 $51,034 - $98,142	1,650 Added 2.89%	58,750 $3.26 Million
Q1 2020 May 14, 2020	SELL	$7.25 - $19.22 $13,775 - $36,518	-1,900 Reduced 3.22%	57,100 $524,000
Q2 2019 Aug 14, 2019	BUY	$15.01 - $18.89 $249,166 - $313,574	16,600 Added 39.15%	59,000 $1.12 Million
Q4 2018 Feb 13, 2019	BUY	$10.77 - $18.44 $90,468 - $154,896	8,400 Added 24.71%	42,400 $738,000
Q2 2018 Aug 13, 2018	BUY	$9.6 - $14.6 $326,400 - $496,400	34,000 New	34,000 $330,000

Others Institutions Holding VCEL

# of Institutions

276

Shares Held

48.5M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.67B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Vericel Corp Transaction History